Riskpilot← Back to searchSign inGet full accessCountagen AB
ABActiveOrg 5592919681Nobels Väg 16Research and experimental development on natural sciences and engineering · NACE 7210Est. 20201-4 employees
Revenue 2024
SEK 99K
-9900100% vs 2023
EBITDA margin
-10262.6%
-46% vs 2023
Equity ratio
85.8%
Financial strength
Net profit 2024
SEK -10,2M
-46% vs 2023
| Revenue | SEK 99K | -9900100% |
| EBITDA | SEK -10,2M | -46% |
| Net profit | SEK -10,2M | -46% |
| Total assets | SEK 7M | -24% |
| Equity | SEK 6M | -27% |
| Employees | — | — |
Legal name
Countagen AB
Org number
5592919681
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 december 2020
Share capital
SEK 68 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva analys av biomolekyler och därmed förenlig verksamhet.
Address
Nobels Väg 16
Email
felix@countagen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 99 |
| Staff expenses | — | — | −2 705 | — |
| EBITDA | −2 119 | −3 916 | −6 951 | −10 160 |
| Depreciation & amort. | −0 | −0 | — | −0 |
| EBIT | −2 119 | −3 916 | −6 951 | −10 160 |
| Net financials | −95 | −1 | −1 | — |
| Profit before tax | −2 214 | −3 917 | −6 952 | −10 160 |
| Tax | −0 | −0 | — | −0 |
| Net profit | −2 214 | −3 917 | −6 952 | −10 160 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 220 | 7 922 | 9 227 | 7 003 |
| Equity | −175 | 7 503 | 8 218 | 6 007 |
| Long-term debt | 0 | 0 | — | 0 |
| Short-term debt | 1 395 | 419 | 1 010 | 996 |
| Total debt | 1 395 | 419 | 1 010 | 996 |
EBITDA margin
-10262.6%
This company
15.8%
Market median
-65053% vs market
20212024
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
20212024
Return on equity
-169.1%
This company
18.4%
Market median
-1019% vs market
20212024
Net profit margin
-10262.6%
This company
8.1%
Market median
-126799% vs market
20212024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FN Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
DJ Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Countagen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Felix Neumann | Chief Executive Officer | 0 companies |
| Dag Jonas Olsson | Audit | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Mårten Winge | Chairman | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Jon-Sverre Schanche | Board of Directors | 0 companies |
| Mats Bo Johan Nilsson Bernitz | Board of Directors | 0 companies |
| Stina Elna Josefin Wallmark | Board of Directors | 0 companies |